Pharmaceuticals Bayer: Science For A Better Life

You need commitment, focus and passion to find new ways to fight the diseases of this world: innovation is at the heart of it.

Innovation + Partnering

When patients become our experts
by Stefan Oelrich
orange

Innovation + Partnering

Artificial Intelligence – Technology-driven disease prediction to advance patient care
by Dr. Michael Devoy
orange

Innovation + Partnering

Artificial Intelligence – Can AI improve cardiovascular disease outcomes?
by Sebastian Guth
orange

Treatment + Care

Genomic Cancer Testing: See the Real Picture of a Cancer Diagnosis
blue

Innovation + Partnering

AI in drug discovery – Accelerating the development of new treatments
by Joerg Moeller
orange

Innovation + Partnering

Artificial Intelligence - when we suddenly know what we don’t know
by Stefan Oelrich
orange

Innovation + Partnering

How the immune system fights cancer
The promise of immuno-oncology
orange

Innovation + Partnering

Starving cancer cells
Targeting cancer via its DNA
orange

Innovation + Partnering

United to improve patients’ lives
An interview with Broad Institute scientist, Steven Ferrara
orange

Innovation + Partnering

Harnessing the power of alpha radiation
Potential for patients with difficult-to-treat tumors
orange

Treatment + Care

How genomic testing helps patients
blue

Commitment + Responsibility

Rising concerns for pharmaceutical innovation in Japan
green

Treatment + Care

What is TRK fusion cancer and how can we detect it?
blue

Treatment + Care

Testing for TRK fusion cancer
blue
Benefits and risks of drugs

Benefits and risks of drugs
green

Treatment + Care

The first treatment for TRK fusion cancer approved by U.S. FDA
blue

Treatment + Care

Looking after yourself while caring for a loved one
blue

Treatment + Care

What you might not know about heart and blood scans
blue

Innovation + Partnering

The future of cancer therapy is now
orange

Treatment + Care

Living with prostate cancer
blue

Treatment + Care

What you need to know about cancer genomics
blue

Innovation + Partnering

From molecules to medicine
Drug development: The R&D journey
orange
Healthy aging

Healthy aging
green
Health policy

Health policy
green

Innovation + Partnering

Why we partner
orange

Argentina

Chagas Disease

“We believe Chagas is a children’s disease”, Dr Jaime Altcheh says, formulating an altogether radical theory about one of the greatest scourges to afflict Latin America.
Social Channels

FaCEBOOK·3 days

We know it’s important to take our medication, but remembering to take it and at the right time can be difficult.

How do you avoid forgetting? Share your tips below!

twitter·9 hours

Patient perspectives are becoming increasingly important to determine clinical outcomes. Therefore quantitative mea…

youtube·11 months

Fish Soup | Easy Healthy Recipes #10

Visit us on Facebook
Visit us on Twitter
Visit us on YouTube
Bayer sponsored clinical studies

Treatment + Care

Bayer trial finder

www.clinicaltrials.gov

Clinicaltrials.gov

www.clinicalstudydatarequest.com

Data sharing portal

Latest press release

Find us in your country

News

2019-06-04

Bayer and Arvinas, Inc. to develop novel Proteolysis-Targeting Chimera candidates for humans and plants

2019-06-03

New data on larotrectinib efficacy in patients with TRK fusion cancer and primary CNS tumors or brain metastases presented at ASCO 2019

2019-05-31

Bayer’s darolutamide plus androgen deprivation therapy (ADT) delays worsening of disease-related symptoms and maintains quality of life beyond end of study treatment compared to placebo plus ADT in men with non-metastatic castration-resistant prostate cancer

2019-05-29

Bayer and Foundation Medicine announce global collaboration to develop next-generation sequencing (NGS)-based companion diagnostics (CDx) in oncology

2019-05-29

Bayer receives U.S. FDA breakthrough therapy designation for copanlisib for the treatment of marginal zone lymphoma
Press center